homoarginine has been researched along with Cardiovascular Diseases in 31 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 26 (83.87) | 24.3611 |
| 2020's | 5 (16.13) | 2.80 |
| Authors | Studies |
|---|---|
| Atzler, D; Böger, R; Choe, CU; Kleist, CJ; Schönhoff, M; Schwedhelm, E; Wicha, SG | 1 |
| Albrecht, MH; Alizadeh, LS; Bernatz, S; Booz, C; D'Angelo, T; Eichler, K; Gruber-Rouh, T; Gruenewald, LD; Hardt, SE; Koch, V; Leistner, DM; Mahmoudi, S; Martin, SS; März, W; Nour-Eldin, NA; Scholtz, JE; Vogl, TJ; Yel, I | 1 |
| Baach, F; Böger, R; Choe, CU; Lezius, S; Meyer, B; Neu, A; Oh, J; Schwedhelm, E | 1 |
| Böger, R; Hannemann, J; Laing, A; Middleton, B; Schwedhelm, E; Skene, DJ | 1 |
| Atzler, D; Ayers, CR; de Lemos, JA; Gore, MO; Hackler, E; Khera, A; Lew, J; Lewis, A; Neeland, I; Omland, T; Rohatgi, A | 1 |
| Bakker, SJL; de Borst, MH; Hanff, E; Kayacelebi, AA; Minovic, I; Post, A; Said, MY; Tsikas, D; van den Berg, E; van Goor, H | 1 |
| Böger, R; Botha-Le Roux, S; Fourie, CMT; Mels, CMC; Mokhaneli, MC; Schwedhelm, E | 1 |
| Hutri-Kähönen, N; Jula, A; Juonala, M; Kähönen, M; Kangas, AJ; Lehtimäki, T; März, W; Meinitzer, A; Oksala, N; Raitakari, OT; Seppälä, I; Soininen, P | 1 |
| Carru, C; Mangoni, AA; Paliogiannis, P; Zinellu, A | 1 |
| Brodmann, M; Gary, T; Hackl, G; Hafner, F; Jud, P; Meinitzer, A; Seinost, G; Verheyen, N | 1 |
| Adams, S; Che, D; Farouk, MH; Hailong, J; Qin, G; Rui, H | 1 |
| Fromm, MF; König, J; Maas, R; Taghikhani, E | 1 |
| Jarzebska, N; Karetnikova, ES; Lentz, SR; Markov, AG; Rodionov, RN; Weiss, N | 1 |
| Auge, D; Chafai, A; Fromm, MF; Gessner, A; Maas, R; Mieth, M; Müller, F | 1 |
| Boehm, BO; Drechsler, C; Fahrleitner-Pammer, A; Hoffmann, MM; Huang, J; Kähönen, M; Kienreich, K; Kleber, ME; Koenig, W; Krane, V; Laaksonen, R; Lehtimäki, T; Lyytikäinen, LP; Mäkelä, KM; März, W; Meinitzer, A; Oksala, N; Pilz, S; Raitakari, OT; Raitoharju, E; Seppälä, I; Tomaschitz, A; Wanner, C | 1 |
| Dekker, JM; Drechsler, C; Kienreich, K; März, W; Meinitzer, A; Nijpels, G; Pilz, S; Rutters, F; Scheffer, PG; Stehouwer, CD; Teerlink, T; Tomaschitz, A | 1 |
| Goniewicz, ML; Kurek, J; Prokopowicz, A; Radek, M; Sobczak, A; Szula, M; Zaciera, M | 2 |
| Beckmann, B; Gutzki, FM; Jordan, J; Kayacelebi, AA; Tsikas, D | 1 |
| Kayacelebi, AA; Tsikas, D | 1 |
| Atzler, D; Böger, RH; Friedrich, N; Ittermann, T; Nauck, M; Schwedhelm, E | 1 |
| Doerfer, J; Grulich-Henn, J; Grünert, SC; Holder, M; Krebs, A; Lichte, K; Schmidt-Trucksäss, A; Schwab, KO; Stier, B; Winkler, K; Wöhrl, J | 1 |
| Atzler, D; Ayers, CR; Böger, RH; Choe, CU; de Lemos, JA; Gore, MO; McGuire, DK; Schwedhelm, E | 1 |
| Döner, U; Düngen, HD; Duvinage, A; Edelmann, F; Gaksch, M; Gelbrich, G; Kienreich, K; Kunde, J; März, W; Meinitzer, A; Pieske, B; Pilz, S; Schmidt, A; Stahrenberg, R; Tomaschitz, A; Wachter, R | 1 |
| Atzler, D; Choe, CU; Schwedhelm, E | 1 |
| Batkai, S; Engeli, S; Jordan, J; Kayacelebi, AA; May, M; Tsikas, D | 1 |
| Abedini, S; Drechsler, C; Fellstrom, B; Holdaas, H; Jardine, AG; März, W; Meinitzer, A; Pihlstrøm, H; Pilz, S; Tomaschitz, A; Wanner, C | 1 |
| Aasarød, KI; Åsberg, A; Hov, GG; Sagen, E | 1 |
| Appelbaum, S; Atzler, D; Beutel, ME; Blankenberg, S; Blettner, M; Böger, RH; Cordts, K; Lackner, KJ; Münzel, T; Ojeda, FM; Pfeiffer, N; Schwedhelm, E; Wild, PS; Zeller, T | 1 |
| Bode-Böger, SM; Brilloff, S; Burdin, D; Cellini, B; Demyanov, A; Jarzebska, N; Kolouschek, A; Leiper, J; Maas, R; Martens-Lobenhoffer, J; Oppici, E; Rodionov, RN; Weiss, N | 1 |
| Blom, HJ; Davids, M; Ndika, JD; Salomons, GS; Teerlink, T | 1 |
6 review(s) available for homoarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Homoarginine in the cardiovascular system: Pathophysiology and recent developments.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Homoarginine; Humans | 2023 |
Homoarginine and all-cause mortality: A systematic review and meta-analysis.
Topics: Adult; Aged; Aged, 80 and over; Cardiovascular Diseases; Cause of Death; Female; Homoarginine; Humans; Kaplan-Meier Estimate; Kidney Diseases; Male; Middle Aged; Observational Studies as Topic | 2018 |
Novel Biosynthesis, Metabolism and Physiological Functions of L-Homoarginine.
Topics: Amidinotransferases; Animals; Biosynthetic Pathways; Cardiovascular Diseases; Diabetes Mellitus, Type 2; Energy Metabolism; Female; Fetal Growth Retardation; Homoarginine; Humans; Pregnancy; Renal Insufficiency, Chronic | 2019 |
Is Homoarginine a Protective Cardiovascular Risk Factor?
Topics: Animals; Biomarkers; Cardiotonic Agents; Cardiovascular Diseases; Disease Models, Animal; Female; Homoarginine; Humans; Male; Mice; Mice, Knockout; Risk Factors; Sensitivity and Specificity | 2019 |
Genome-wide association study identifies 3 genomic loci significantly associated with serum levels of homoarginine: the AtheroRemo Consortium.
Topics: Adult; Aged; Arginine; Cardiovascular Diseases; Chromosomes, Human; Enzymes; Female; Genetic Loci; Genome-Wide Association Study; Genotype; Homoarginine; Humans; Male; Middle Aged; Mitochondria; Polymorphism, Single Nucleotide | 2013 |
L-homoarginine and cardiovascular disease.
Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Animals; Cardiovascular Diseases; Developmental Disabilities; Energy Metabolism; Homoarginine; Humans; Intellectual Disability; Speech Disorders | 2015 |
4 trial(s) available for homoarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Tobacco smoking decreases plasma concentration of the emerging cardiovascular risk marker, L-homoarginine.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Creatinine; Cross-Sectional Studies; Female; History, Ancient; Homoarginine; Humans; Male; Middle Aged; Risk Factors; Smoking | 2014 |
Decreased levels of homoarginine and asymmetric dimethylarginine in children with type 1 diabetes: associations with cardiovascular risk factors but no effect by atorvastin.
Topics: Adolescent; Anticholesteremic Agents; Arginine; Atorvastatin; Cardiovascular Diseases; Diabetes Mellitus, Type 1; Female; Follow-Up Studies; Glycated Hemoglobin; Heptanoic Acids; Homoarginine; Humans; Lipids; Male; Pilot Projects; Pyrroles; Risk Factors; Treatment Outcome | 2015 |
Homoarginine and Clinical Outcomes in Renal Transplant Recipients: Results From the Assessment of Lescol in Renal Transplantation Study.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Chi-Square Distribution; Creatinine; Disease Progression; Europe; Fatty Acids, Monounsaturated; Female; Fluvastatin; Graft Rejection; Graft Survival; Homoarginine; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Indoles; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; North America; Proportional Hazards Models; Prospective Studies; Renal Insufficiency; Risk Factors; Time Factors; Treatment Outcome | 2015 |
Reference intervals of plasma homoarginine from the German Gutenberg Health Study.
Topics: Adult; Aged; Cardiovascular Diseases; Case-Control Studies; Female; Germany; Homoarginine; Humans; Male; Middle Aged; Prevalence; Reference Values; Risk Factors; Tandem Mass Spectrometry | 2016 |
21 other study(ies) available for homoarginine and Cardiovascular Diseases
| Article | Year |
|---|---|
Population kinetics of homoarginine and optimized supplementation for cardiovascular risk reduction.
Topics: Cardiovascular Diseases; Dietary Supplements; Heart Disease Risk Factors; Homoarginine; Humans; Kinetics; Risk Factors | 2022 |
Developmental dynamics of homoarginine, ADMA and SDMA plasma levels from birth to adolescence.
Topics: Adolescent; Adult; Arginine; Cardiovascular Diseases; Child; Child, Preschool; Heart; Homoarginine; Humans; Infant; Infant, Newborn; Renal Insufficiency, Chronic | 2023 |
Diurnal Variation of L-Arginine and the Cardiovascular Risk Markers Asymmetric and Symmetric Dimethylarginine and Homoarginine in Rotating Night Shift Workers and Controls.
Topics: Amino Acids; Arginine; Cardiovascular Diseases; Heart Disease Risk Factors; Homoarginine; Humans; Hydrocortisone; Melatonin; Risk Factors | 2023 |
Racial Differences in Cardiovascular Biomarkers in the General Population.
Topics: Adiponectin; Adult; Albuminuria; Antibodies, Antinuclear; Arginine; Biomarkers; Black or African American; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Female; Fibrin Fibrinogen Degradation Products; Homoarginine; Humans; Interleukin-1 Receptor-Like 1 Protein; Leptin; Linear Models; Lipoprotein(a); Male; Middle Aged; Multivariate Analysis; Natriuretic Peptide, Brain; Osteoprotegerin; Peptide Fragments; Proportional Hazards Models; Receptor for Advanced Glycation End Products; Troponin T; White People | 2019 |
High plasma guanidinoacetate-to-homoarginine ratio is associated with high all-cause and cardiovascular mortality rate in adult renal transplant recipients.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Cross-Sectional Studies; Female; Follow-Up Studies; Glycine; Homoarginine; Humans; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Risk Factors | 2019 |
L-homoarginine is associated with decreased cardiovascular- and all-cause mortality.
Topics: Adult; Aged; Cardiovascular Diseases; Cause of Death; Female; Homoarginine; Humans; Male; Middle Aged; Mortality; Multivariate Analysis; Proportional Hazards Models; Protective Factors | 2021 |
The biomarker and causal roles of homoarginine in the development of cardiometabolic diseases: an observational and Mendelian randomization analysis.
Topics: Adult; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Homoarginine; Humans; Male; Mendelian Randomization Analysis; Metabolic Diseases; Prospective Studies; Risk Assessment; Young Adult | 2017 |
Homoarginine/ADMA ratio and homoarginine/SDMA ratio as independent predictors of cardiovascular mortality and cardiovascular events in lower extremity arterial disease.
Topics: Aged; Arginine; Biomarkers; Cardiovascular Diseases; Cardiovascular System; Female; Homoarginine; Humans; Incidence; Lower Extremity; Male; Middle Aged; Prospective Studies; Risk Factors; Vascular Diseases | 2018 |
The renal transport protein OATP4C1 mediates uptake of the uremic toxin asymmetric dimethylarginine (ADMA) and efflux of cardioprotective L-homoarginine.
Topics: Arginine; Cardiovascular Diseases; HEK293 Cells; Homoarginine; Humans; Inhibitory Concentration 50; Kidney; Kinetics; Organic Anion Transporters; Toxins, Biological | 2019 |
Establishment of reference values for the lysine acetylation marker N
Topics: Adolescent; Adult; Arginine; Biomarkers; Cardiovascular Diseases; Carnitine; Chromatography, Liquid; Citrulline; Creatinine; Female; Homoarginine; Humans; Lysine; Male; Middle Aged; Ornithine; Reference Values; Renal Insufficiency, Chronic; Tandem Mass Spectrometry; Young Adult | 2019 |
Homoarginine and mortality in an older population: the Hoorn study.
Topics: Age Factors; Aged; Cardiovascular Diseases; Epidemiologic Methods; Female; Homoarginine; Humans; Male; Middle Aged; Netherlands | 2014 |
GC-MS and GC-MS/MS measurement of the cardiovascular risk factor homoarginine in biological samples.
Topics: Arginine; Cardiovascular Diseases; Female; Gas Chromatography-Mass Spectrometry; Homoarginine; Humans; Male; Risk Factors; Sputum | 2014 |
Do homoarginine and asymmetric dimethylarginine act antagonistically in the cardiovascular system?
Topics: Cardiovascular Diseases; Female; Homoarginine; Humans; Male; Smoking | 2014 |
Do homoarginine and asymmetric dimethylarginine act antagonistically in the cardiovascular system?
Topics: Cardiovascular Diseases; Female; Homoarginine; Humans; Male; Smoking | 2014 |
Serum reference intervals of homoarginine, ADMA, and SDMA in the study of health in Pomerania.
Topics: Adult; Aged; Arginine; Biomarkers; Body Mass Index; Cardiovascular Diseases; Chromatography, High Pressure Liquid; Female; Homoarginine; Humans; Male; Middle Aged; Reference Values; Renal Insufficiency, Chronic; Risk Factors; Tandem Mass Spectrometry | 2014 |
Homoarginine and cardiovascular outcome in the population-based Dallas Heart Study.
Topics: Adult; Aorta; Biomarkers; Cardiovascular Diseases; Cross-Sectional Studies; Female; Follow-Up Studies; Homoarginine; Humans; Incidence; Male; Middle Aged; Proportional Hazards Models; Risk Factors; Texas; Ultrasonography | 2014 |
Associations of methylarginines and homoarginine with diastolic dysfunction and cardiovascular risk factors in patients with preserved left ventricular ejection fraction.
Topics: Aged; Aged, 80 and over; Arginine; Biomarkers; Cardiovascular Diseases; Echocardiography, Doppler; Female; Heart Failure, Diastolic; Homoarginine; Humans; Logistic Models; Male; Middle Aged; Nitric Oxide; Reference Values; Risk Factors; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume | 2014 |
Plasma and tissue homoarginine concentrations in healthy and obese humans.
Topics: Adult; Bariatric Surgery; Body Mass Index; Cardiovascular Diseases; Female; Homoarginine; Humans; Male; Obesity; Risk Factors | 2015 |
Arginine, dimethylated arginine and homoarginine in relation to cardiovascular risk in patients with moderate chronic kidney disease.
Topics: Adult; Aged; Arginine; Biomarkers; Cardiovascular Diseases; Female; Follow-Up Studies; Homoarginine; Humans; Male; Middle Aged; Prospective Studies; Renal Insufficiency, Chronic; Risk Factors | 2015 |
A Novel Pathway for Metabolism of the Cardiovascular Risk Factor Homoarginine by alanine:glyoxylate aminotransferase 2.
Topics: Animals; Cardiovascular Diseases; Genome-Wide Association Study; Hep G2 Cells; Homoarginine; Humans; Metabolic Networks and Pathways; Metabolic Syndrome; Mice; Mice, Knockout; Mice, Transgenic; Risk Factors; Stroke; Transaminases | 2016 |
Promiscuous activity of arginine:glycine amidinotransferase is responsible for the synthesis of the novel cardiovascular risk factor homoarginine.
Topics: Amidinotransferases; Amino Acid Metabolism, Inborn Errors; Cardiovascular Diseases; Developmental Disabilities; Homoarginine; Humans; Infant, Newborn; Intellectual Disability; Male; Risk Factors; Speech Disorders; Substrate Specificity | 2012 |